INTERNATIONAL PATENT: QIAGEN GMBH FILES APPLICATION FOR "METHOD FOR ISOLATING NUCLEIC ACIDS FROM AN INHIBITOR RICH BIOLOGICAL SAMPLE"

GENEVA, March 9 -- QIAGEN GMBH (Qiagen StraBe 140724 Hilden) filed a patent application (PCT/EP2024/074495) for "METHOD FOR ISOLATING NUCLEIC ACIDS FROM AN INHIBITOR RICH BIOLOGICAL SAMPLE" on Sep 02, 2024. With publication no. WO/2025/046143, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): O'NEIL, Dominic (c/o QIAGEN GmbHQiagen StraBe 140724 Hilden), SCHROEER, Stefanie (c/o QIAGEN GmbHQiagen StraBe 140724 Hilden)

Abstract: The present invention provides a method for isolating nucleic acids from a sample, preferably a ...